Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | FGFR4 | P22455 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL1229946 | 0.94 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL1229334 | 0.94 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL6880358 | 0.94 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL416966 | 0.84 | LMNA (0.47) | TSHRALDH1A1LMNAFGFR4CA1 | |
| Acrylic Acid SCHEMBL29379504 | 0.82 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL30363227 | 0.82 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL29143555 | 0.82 | TSHR (0.40) | TSHRALDH1A1LMNAFGFR4CA2 | |
| Acrylic Acid SCHEMBL28365278 | 0.81 | LMNA (0.44) | TSHRALDH1A1LMNAFGFR4CA1 | |
| Acrylic Acid SCHEMBL29418960 | 0.81 | LMNA (0.44) | TSHRALDH1A1LMNAFGFR4CA1 | |
| Acrylic Acid SCHEMBL28869086 | 0.81 | LMNA (0.44) | TSHRALDH1A1LMNAFGFR4CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1746134-B1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | KANEKA CORP (JP) | 2019-09-04 | — | — | EP | disclosed |
| EP-1746135-B1 | CURABLE COMPOSITION | KANEKA CORP (JP) | 2019-05-29 | — | — | EP | disclosed |
| US-7973108-B2 | Curable composition | KANEKA CORPORATION (JP) | 2011-07-05 | — | — | US | disclosed |
| US-7943798-B2 | Process for preparing metal salts of unsaturated, short-chain carboxylic acids and use thereof | SASOL SOLVENTS GERMANY GMBH (DE) | 2011-05-17 | — | — | US | disclosed |
| US-7910681-B2 | Curable composition having improved adhesion | KANEKA CORPORATION (JP) | 2011-03-22 | — | — | US | disclosed |
| US-7893170-B2 | Curable composition having improved curability and adhesion | KANEKA CORPORATION (JP) | 2011-02-22 | — | — | US | disclosed |
| US-20080319152-A1 | Curable Composition | KANEKA CORPORATION (JP) | 2008-12-25 | — | — | US | disclosed |
| EP-1641735-B1 | METHOD FOR THE PRODUCTION OF METAL SALTS OF SHORT-CHAINED, UNSATURATED, CARBOXYLIC ACIDS AND USE THEREOF | SASOL SOLVENTS GERMANY GMBH (DE) | 2008-09-24 | — | — | EP | disclosed |
| US-20080194773-A1 | Polysiloxane from silanetriol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-08-14 | — | — | US | disclosed |
| US-20080076878-A1 | Organic polymer having a silane tiol group, a titanium, aluminum or a zirconium catalyst, and a low molecular weight compound containing a hydrolyzable silicon group; sealants, adhesives | KANEKA CORPORATION (JP) | 2008-03-27 | — | — | US | disclosed |
| US-20070287747-A1 | Process for Preparing Metal Salts of Unsaturated, Short-Chain Carboxylic Acids and Use Thereof | SASOL SOLVENTS GERMANY GMBH (DE) | 2007-12-13 | — | — | US | disclosed |
| EP-1746134-A1 | CURABLE COMPOSITION WITH IMPROVED CURABILITY AND ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746135-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1746133-A1 | CURABLE COMPOSITION IMPROVED IN ADHESIVENESS | Kaneka Corporation (JP) | 2007-01-24 | — | — | EP | disclosed |
| EP-1641735-A2 | METHOD FOR THE PRODUCTION OF METAL SALTS OF SHORT-CHAINED, UNSATURATED, CARBOXYLIC ACIDS AND USE THEREOF | SASOL Germany GmbH (DE) | 2006-04-05 | — | — | EP | disclosed |
| WO-2005005364-A2 | METHOD FOR THE PRODUCTION OF METAL SALTS OF SHORT-CHAINED, UNSATURATED, CARBOXYLIC ACIDS AND USE THEREOF | SASOL GERMANY GMBH (DE) | 2005-01-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070287747-A1 | Process for Preparing Metal Salts of Unsaturated, Short-Chain Carboxylic Acids and Use Thereof | FASN, ELOVL5, SLC27A2 | TSHR 3524/4885ALDH1A1 140/4885LMNA 1806/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.